ClearPoint Neuro Enters into 10-year Focused Ultrasound Development Partnership with Sungkyunkwan University, South Korea, Further Expanding Our Drug Delivery Ecosystem and Global Footprint
ClearPoint Neuro announced a 10-year development partnership with Sungkyunkwan University in South Korea to enter the focused ultrasound market. The company demonstrated successful preclinical delivery of large molecule tracers across the blood-brain barrier using a prototype system built with the university's SONOCARELAB.
Key figures
- Partnership duration
- 10 years
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.